Beg for Mercy Beg, on your Knee's and Beg..... Giggle!
Please wait to cover I want to see it move nice and slow up to the $3.30 range and then EXPLODE up past $5 in a matter of minutes with you morons chasing all the way...... Giggle
*DJ Prima BioMed Announces New IP For Its Lead IMP321 Development Program
Last update: 29/05/2015 7:00:27 am
Prima BioMed Announces New IP for Its Lead IMP321 Development Program
SYDNEY, AUSTRALIA--(Marketwired - May 29, 2015) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company"), a leading immuno-oncology company, today announced that it has made substantial progress with its lead product, IMP321.
-- Prima advises that it has filed for patent protection over the use of
IMP321 in conjunction with checkpoint inhibitor molecules, which the
company believes gives IMP321 significant clinical and commercial
-- Prima's CEO, Marc Voigt, and CSO & CMO, Professor Frédéric
Triebel, will be attending the Annual Meeting of the American Society of
Clinical Oncology (ASCO) in Chicago to discuss IMP321 with key opinion
leaders in the immuno-oncology field.
New patent filing for IMP321
Prima advises that it has filed a provisional patent application over the use of IMP321 in combination with immune checkpoint inhibitors. This breakthrough science not only bodes well for future clinical work on IMP321; it also offers commercial upside given the widespread expectation that new drugs working through various immune checkpoints will become blockbusters. In addition, this work has allowed Prima to further build on the patent estate protecting IMP321, with patent exclusivity for the product now potentially running to 2035 or beyond if granted and extended.
Professor Frédéric Triebel, CSO & CMO of Prima BioMed, commented, "In the exciting era of cancer therapy that we have moved into thanks to the rise of immuno-oncology, I have long argued that LAG-3 will be a key checkpoint molecule in this revolution. Our recent work combining our soluble LAG-3 product as a dendritic cell activator with T cell targeted checkpoint inhibitors has suggested that our work can play a key role in this second revolution leading to higher response rates through comb
Sentiment: Strong Buy
No your just some shmuck that chased this stock in hopes of a quick buck and got burned, now your here crying about losing your money, your a Moron. Go chase some more as it appears you have no clue as to how to invest or in what. Read the news idiot they have it together and will either partner with a big pharma or be bought out, so quit being a dope.
I agree should be an up day, its the end of month and there will be a lot of rebalancing of portfolios which could bod well for PBMD, still think a buyer or partner is on the horizon and sooner than later.
So was Yahoo thats all I'm saying its never a done deal until its a done deal. I hope it happens for longs but when people jump on the bandwagon for a quick buck the street can be very punishing as its easy money for insiders.
just asking what the expectations of the downside are. Yahoo was to be bought by Microsoft and the hype was insane by CNBC and Bloomberg with them meeting over a weekend to finalize the deal, and then Microsoft walked away, which was stupid on their part but it Crushed Yahoos stock for more than 2 years. It dropped 40% almost premarket and settled in the 25% down range and stayed there. So everyone understand its not a done deal until its a done deal be carefull.
I love watching someone panic post just shows how Scared they are, and you should be.....
I agree, drys has positioned itself for another huge run up as it has done in its past, Shorts and Bashers are going be trying to spin this but not gonna happen, up up up drys will go.......